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httpEndovascular repair of aortoiliac aneurysmal disease
with the helical iliac bifurcation device and the
bifurcated-bifurcated iliac bifurcation device
Shen Wong, MD, Roy K. Greenberg, MD, Chase R. Brown, BS, Tara M. Mastracci, MD, James Bena, MS,
and Matthew J. Eagleton, MD, Cleveland, Ohio
Background: Iliac branch device (IBD) treatment of common and internal iliac artery (CIA and IIA) aneurysms has been
controversial in the context of available embolization techniques or off-label adjunctive procedures. Two devices exist,
a straight IBD (S-IBD) and a helical IBD (H-IBD). We report our midterm results with the latter and present outcomes
with a third device intended to treat disease in the presence of short CIAs termed the bifurcated-bifurcated IBD
(BB-IBD).
Methods: Data were prospectively collected from IBD-treated patients with infrarenal aortoiliac or thoracoabdominal
aortoiliac aneurysms. Preoperative aneurysmal characteristics were collected in accordance with the endovascular
reporting standards document, including presence of IIA stenosis, CIA diameters, and the presence of an IIA aneurysm.
Technical success was deﬁned as IBD device placement, branch placement, and patency without type I or III endoleak at
implantation in addition to 24 hours survival. Follow-up computed tomography scans at 1, 6 (optional), 12 months, and
annually thereafter were performed and reinterventions, sac morphology changes, and endoleaks noted. Survival and
patency were evaluated with life-table analyses, and differences among anatomic groups were compared with log-rank
tests, whereas t-tests and Fisher exact tests were used to compare simple variables.
Results: Between 2003 and 2012, 138 IBD devices were placed into 130 patients (98 H-IBD and 40 BB-IBD). Median
follow-up was 20.3 months (range, 1-72 months) with 30- day, 12-month, 3- and 5-year survival rates of 99%, 90%, 79%,
and 62%, respectively. Technical success was 94%, and branch patency was 94.6% at 30 days and 81.8% at 5 years. Thirty-
ﬁve percent (35%) of branches were placed into patients with IIA aneurysms (in addition to their proximal disease), 20%
into stenotic IIAs, and 46% into iliac systems with narrow (<16 mm) CIAs. Technical success was signiﬁcantly lower in
patients with IIA stenosis (81.5 vs 96.4%; Fisher exact test, P[ .015) but not affected by the presence of an IIA aneurysm
or narrow CIA. Branch patency was similar in all groups throughout follow-up. No stent fractures or component sepa-
rations were noted in the IBDs or mating devices throughout the study period.
Conclusions: The H-IBD and BB-IBD conﬁgurations have high technical success and acceptable long-term patency for the
treatment of CIA and IIA aneurysms, including those with challenging anatomy difﬁcult to treat with the straight branch
design. (J Vasc Surg 2013;58:861-9.)1 2In aortoiliac aneurysm repair, preservation of hypogas-
tric blood ﬂow has an important role in preventing buttock
claudication as well as less common complications including
ischemic colitis, gluteal necrosis, spinal cord ischemia, and
sexual dysfunction. Endovascular techniques such as thethe Department of Vascular Surgery, Cleveland Clinic.
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dures3,4 have been employed to preserve antegrade internal
iliac artery (IIA) ﬂow. Yet, all of these methods have the
potential for persistent pressurization of diseased common
iliac arteries (CIAs) and lack appropriate preclinical testing
or manufacturer backing. Branched device treatment of
CIA/IIA aneurysms has been described, but large series
with long-term follow-up are scarce.5,6 Two device versions
(Fig 1), a straight branch-iliac branch device (S-IBD) and
helical branch-iliac branch device (H-IBD), both by Cook
Inc (Bloomington, Ind), are commercially available outside
the United States, while both devices are undergoing clinical
trials in the United States. Technical differences include the
length of overlap with the mating internal iliac stent grafts,
the mechanism of directing ﬂow into the branch, and
(historically) the use of self-expanding rather than balloon-
expandable stent grafts within the IIA. Both devices are
unable to handle short CIAs without the addition of two or
more modular joints within the aneurysm sac, potentially861
Fig 1. A, This ﬁgure demonstrates the differences between the three devices. The helical iliac branch device (H-IBD) is
about 5 cm long and, thus, extends 1 cm into the aortic portion on an abdominal aortic aneurysm if the common iliac
artery (CIA) is slightly longer than 4 cm, placing two modular joints within a potentially large volume. If the CIA is
shorter, then the device is even higher potentially compromising durability more and making the procedure much more
challenging. The bifurcated-bifurcated IBD (BB-IBD) is designed for shorter CIAs, by allowing for the treatment of
aneurysms involving CIAs as short as 2 to 2.5 cm without difﬁculty. Longer CIA aneurysms can also be treated, but the
mating device to reach the internal iliac artery (IIA) landing zone must then be longer as well. Once the BB-IBD was
developed, the need to treat CIAs that were shorter than 5.5 to 6 cm was obliviated, so the H-IBD2 was developed by
lengthening the overlap with the aortic component to addmore security to the joint.B,These images represent the actual
devices. The straight IBD (S-IBD) is depicted ﬁrst; note the minimal (10-15 mm) overlap zone in contrast to the H-IBD
where the wrap of the branch around the device extends the overlap zone to 27 mm. The H-IBD2 has the extended
overlap zone with the mating component increasing it from 22 mm in the H-IBD1 to 31 mm in the H-IBD2. The BB-
IBD is designed tomate with a 24-mm-diameter tubular graft in the distal aorta. This is identical to the distal components
used in fenestrated and branched grafts, making this an ideal distal component for such cases, replacing the distal
bifurcated component that would have to be combined with an IBD to achieve treatment of a CIA or IIA aneurysm.
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issue, a third device, termed the bifurcated-bifurcated iliac
branch device (BB-IBD) was developed. This deviceincorporates a helical IBD into the ipsilateral leg of an aortic
bifurcated graft. This article describes our experiencewith the
H-IBD and BB-IBD.
Fig 2. This image superimposes a completed iliac branch device
(IBD) with the underlying angiogram depicting the relationship
between the natural lay of the mating Fluency stent graft with the
intended treatment anatomy.
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Two physician-sponsored investigational device exemp-
tion trials, one for infrarenal abdominal aortic aneurysms
(NIH study #5834141) and one for thoracoabdominal
aortic aneurysms (TAAAs: #583050), incorporated the use
of IBD beginning in 2003 for patients with concomitant
CIA and/or IIA aneurysms. All patients were considered
high risk for surgical repair and signed informed consent
approved by our Institutional Review Board. Inclusion,
exclusion, and other trial details have been previously
described,7,8 with those speciﬁc to the IBD detailed below.
Patients were evaluated with preoperative high-resolution
computed tomography, which was postprocessed using
a three-dimensional workstation (Aquarius Intuition; Terar-
econ, Santa Rosa Calif). Patients with CIA aneurysmal
involvement were considered for treatment with an IBD
based on the following speciﬁc criteria: (1) an IIA circulation
distal ﬁxation site (main trunk or divisional branch)#10mm
diameter and $10 mm length; (2) iliac vasculature not
precluding delivery or device orientation (extreme angula-
tion or calciﬁc stenosis); and (3) activity level that would
be signiﬁcantly altered by claudication or, a signiﬁcant risk
of spinal cord ischemia with TAAA repair.
Following BB-IBD availability in June 2008, patients
with CIAs <5.5 cm in length were preferentially treated
with this device, whereas CIAs >6 cm in length were
treated with an H-IBD (Fig 1, A). Device choice in
patients with CIAs 5.5 to 6 cm in length was left to the
discretion of the treating physician. After BB-IBD avail-
ability, the H-IBD was no longer needed to treat shorter
CIAs and was therefore modiﬁed with the addition of
a single stent proximally, designed to increase its overlap
with any mating aortic device (H-IBD2; Fig 1). In addi-
tion, nitinol rings were added to the helical branch on
both devices to further reinforce the branch. Patients
treated for bilateral disease received either two H-IBDs
or a BB-IBD and one H-IBD, the latter being implanted
on the side with the longer CIA.
Device descriptions: H-IBD. This device closely
resembles a conventional limb extension with a 27-mm-
long side arm (crimped fabric tube) anastomosed 22 mm
distal to its proximal edge in an end-to-side fashion (31 mm
in theH-IBD2; Fig 1,B). This branch travels in a helical path
(180) around the external posterior portion of the iliac leg
providing an extensive overlap zone with mating devices
while orienting the terminal branch ostium in the line with
the natural direction of IIA ﬂow. This helps minimize any
angulation within any mating stent graft device to optimize
ﬂow dynamics, minimize distraction forces, and decrease
risks of stent fracture (Fig 2). Prior to 2005, twodiameters (6
and 8 mm) were available for the helical branch; after 2005,
8-mmbrancheswere used for all patients. A left-oriented and
a right-oriented device exist and are used in the corre-
sponding CIAs resulting in the distal branch ostium directed
toward the posteromedial aspect of the distal CIA, preferably
in close proximity to the IIA ostium. All common and
external iliac components are 12 mm in diameter, while theoverall device length proximal to the branch terminus is 54
mm (prior to BB-IBD introduction; 63 mm with the
H-IBD2). All devices extend 52 mm distal to the branch
terminus to seal within the external iliac artery (EIA) with
a terminal diameter of 12 mm.
The H-IBD is loaded into a 20F sheath and has a pre-
loaded wire and catheter passing external to the distal
portion of the implant, entering the distal helical branch
ostium and passing through the common iliac segment
exiting the sheath along a grooved pusher device. By
snaring this wire from an alternative access site (contralat-
eral groin or upper extremity), through-and-through access
is established. A sheath (10-12F) is inserted over the
through-and-through wire directly into the helical branch,
through which a steerable catheter-guidewire combination
is used to establish access deep into the IIA circulation
(preferably within the posterior branch). The mating device
(Fluency 10-mm diameter, 6-8 cm in length; CR Bard Inc,
Murray Hill, NJ) is introduced over a stiffer wire and
deployed at the distal landing site, ensuring a minimum
15 to 20 mm overlap with the helical side arm. Additional
Fluency grafts can be used to extend the repair deeper into
the main IIA trunk or, preferably if necessary, into the non-
aneurysmal posterior IIA trunk (after embolization of the
nontreated anterior trunk). The IBD is mated proximally
to the aortic device using a leg extension modiﬁed with
crimps to the distal fabric that interdigitate with crimps
of the proximal H-IBD fabric, increasing the coefﬁcient
of friction and improving the pull-out force.
BB-IBD. This device resembles a bifurcate component
used for fenestrated stent graft completion whose ipsilateral
Table I. Patient demographics
Characteristics
H-IBD
total
BB-IBD
total
Total population 90 40
Age at repair, mean (SD) 71.3 (7.8) 71.4 (8.8)
Maximum aneurysm diameter,
mean (SD)
60.7 (11.0) 59.1 (11.5)
Treated common iliac aneurysm
diameter, mean (SD)
34.6 (12.1) 31.2 (9.9)
Treatment side internal iliac
aneurysm (>10 mm)
31 13
Proximal extent of aneurysm
Infrarenal 43 19
Suprarenal 47 21
Length of treated CIA, mean
(range), mm
68 (25-110) 55 (15-108)
Family history of aneurysms 9 (13.1) 4 (10)
Male sex 83 (94.0) 39 (97.5)
Tobacco history 77 (85.5) 27 (67.5)
Hypertension 38 (42.2) 19 (47.5)
Coronary artery disease 43 (47.8) 23 (57.5)
Diabetes mellitus 22 (24.4) 9 (22.5)
Chronic renal insufﬁciency 14 (15.5) 5 (12.5)
Chronic obstructive pulmonary
disease
22 (24.4) 9 (22.5)
BB-IBD, Bifurcated-bifurcated IBD; CIA, common iliac artery; H-IBD,
helical-IBD; IBD, iliac branch device; SD, standard deviation.
This table depicts the demographics of the patients treated with an H-IBD
vs a BB-IBD.
Data are presented as number (%) unless otherwise indicated.
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manner as the H-IBD described above. This design obvi-
ates the need for leg extensions to join with an aortic
body and is thus preferred in patients with shorter CIAs.
Access from the contralateral side into the helical side
arm is via a fenestration opposite and cranial to the branch
ostium, which is later sealed by an overlaying segment of
fabric and stent. A wire, preloaded through this self-
sealing fenestration directly into the helical side arm, is
snared from the contralateral groin and a 9 to 10F Flexor
sheath (Cook Inc) is placed, allowing IIA access and
stenting in a manner similar to the H-IBD. After IIA
branch completion, removal of the sheath allows the fabric
and stent overlying the self-sealing fenestration to close,
preventing leakage. The BB-IBD mates proximally with
a fenestrated/branched graft (or an aortic cuff for an
infrarenal aneurysm) with the contralateral limb placed in
standard fashion to complete the repair.
Follow-up. Patients were followed with computed
tomography scans within 1 month, optionally at 6 months,
then at 12 months, and annually thereafter. Duplex ultra-
sounds were also obtained for patients treated with fenes-
trated/branched devices. Endovascular results pertaining
to reinterventions, sac morphology changes, and endoleaks
were reported as per the endovascular reporting stan-
dards.9,10 Technical success was deﬁned as IBD device
placement, cannulation, and a patent iliac branch without
evidence of type I or III endoleak, in addition to survival for
24 hours. Severe IIA ostial stenosis was deﬁned as a diameter
reduction of >50% on centerline of ﬂow measurement, and
an IIA aneurysm was deﬁned as >10 mm in diameter. A
narrow CIA bifurcation was deﬁned as a CIA diameter
immediately proximal to the bifurcation of <16 mm, given
that the device plus branch takes up 18 mm of space.
Statistics. Analyses were performed with SAS (v. 9.1;
SAS Inc, Cary, NC) and R2.8 software (Vienna, Austria).
Continuous data were compared using Student t-test.
Patency and mortality were assessed using Kaplan-Meier
life-table analyses and differences between groups were
compared using the log-rank test and truncated when the
standard error exceeded 10%. Correlation coefﬁcients were
calculated using the Spearman’s rank correlation test. A P
value of <.05 conferred statistical signiﬁcance.
RESULTS
From October 2003 to February 2012, 138 helical
branches were placed into 130 patients; 98 branches
were H-IBD, while 40 were BB-IBD. Patient demo-
graphics and aneurysmal diameters are listed in (Table I).
Mean H-IBD follow-up was 24.1 months (range, 1-72)
and BB-IBD 7.7 months (range, 1-24) with an overall
mean of 20.3 months.
The proximal component of the branched graft was
connected to a fenestrated/branched endograft in 70
(51%) patients and an infrarenal graft in 63 (45%) patients.
In ﬁve cases (4%), the IBD was docked into a limb of
a previous aortic repair, with four sealing independently
and one requiring a standard bridging leg extension graft(TFLE 12-37) for connection. Two cases of failed IIA
access required the use of a leg extension (TFLE) to
connect the IBD to the aortic mating device and cover
the ostium of the helical branch (neither case required
embolization of the IIA or developed an endoleak).
Only 10 branches using the 6-mm limb were deployed
(all prior to August 9, 2005). The most commonly used
mating stent graft was the Fluency self-expanding stent
graft (98%) (Fluency; CR Bard Inc), followed by the Via-
bahn (2%) (W. L. Gore, Flagstaff, Ariz). In H-IBDs,
a balloon-expandable stent was deployed within the self-
expanding stent graft sealing within the helical limb to
ensure reinforcement up to the branch ostium in many
cases (90%). This reinforcement was not necessary
following the introduction of nitinol reinforcement rings
along the branch in the H-IBD2. In BB-IBDs, additional
reinforcement was required in 13 of 40 cases, most
commonly when treating extreme anatomies.
Mortality. Thirty patients have expired following
H-IBD or BB-IBD placement. All mortalities were H-IBD
subjects, and only one was an aortic-related death. This
subject had successful H-IBD implantation and an intact
aneurysm repair but expired 6 hours postoperatively from an
autopsy-proven myocardial infarction. For the entire IBD
cohort, Kaplan-Meier calculations estimate a 30-day, 12-
month, 3-year, and 5-year survival rate of 99%, 90%, 79%,
and 62%, respectively (Fig 3). Survival stratiﬁed by proximal
extent of disease (thoracoabdominal vs infrarenal) was
similar (65% vs 60% at 5 years, respectively).
Fig 4. Branch patency for the entire cohort is demonstrated by
the Kaplan-Meier curve in the ﬁgure. Standard error was <10%
throughout.
Fig 3. This Kaplan-Meier curve estimates the survival for all of the
patients in the trial. Through7 years, the standard errorwas under 10%.
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nical success was achieved in 94% of cases; there were nine
technical failures. Eight involved the H-IBD, one a BB-
IBD, and none involving the H-IBD2. The sole BB-IBD
failure related to an inability to cannulate the IIA at the
time of the procedure; the resultant type III endoleak was
rectiﬁed successfully 3 days later with mating stent graft
placement via an arm approach. Of the eight H-IBD
technical failures, one was due to myocardial death as
previously described, ﬁve from failed IIA cannulation, and
two from IBD dislodgement during insertion of more
proximal devices. In each of the latter seven cases, the
helical branch oriﬁce was covered with a limb extension,
and the repairs extended into the EIA. No endoleaks
resulted from these technical failures.
Patency. Estimated patency at 30 days, 12, 24, 48,
and 60 months was 94.6%, 86.4%, 81.8%, 81.8%, and
81.8%, respectively (Fig 4). A total of 18 occlusions were
noted, of which 11 (including the seven technical failures
resulting in occlusion) occurred within 30 days of
implantation. The seven late occlusions occurred between
1 and 26 months postimplantation; 71% of these patients
developed unresolving hip claudication (Table II).
Endoleaks and secondary interventions. There were
four patients with IBD-related endoleaks (two H-IBD and
two BB- IBD), all in patients with IIA aneurysms requiring
sealing within the IIA posterior trunk. All were successfully
treated. Freedom from IBD-related endoleak was 96% at 5
years. There were 12 IBD-related secondary interventions:
four involved endoleak treatment (listed above), one had
embolization of a middle sacral artery through feeder
vessels of the IBD side,11 and four had thrombosed EIA
limbs of the IBD (three were reopened with thrombolysis
and supplemental self-expanding nitinol stents distally, and
one required a femoral-femoral bypass). All have remained
patent through follow-up. The remaining three reinter-
ventions included the completion of a planned staged
procedure, attempted recanalization of an occluded iliacbranch, and stenting of a stenosis at a junction between
a crimped limb and an H-IBD. No stent fractures or
component separations of the IBD or mating stent grafts
were noted on follow-up.
Morphologic outcomes. While difﬁcult to separate
sac behavior related to an IBD vs the primary aortic
component, iliac aneurysmal sac regression was most
commonly observed (79 of 118 [67%]), while the aneu-
rysm sac remained stable in the remainder, with no cases
of sac growth.
Common iliac artery length. Mean CIA length
treated with the H-IBD was 66.5 mm (32 patients <50
mm) prior to 2008 and 71.0 mm after BB-IBD availability
with none <50 mm. CIA length in BB-IBD was 54.9 mm
(range, 15-108 mm). Because of the mating beneﬁts of the
BB-IBD device with fenestrated or branched components,
the BB-IBD was used preferentially in the setting of longer
CIA during such cases (Fen 56.9mm vs non-Fen 49.5mm).
Internal iliac artery aneurysm. Forty-ﬁve (45) of 138
helical branches were placed into IIA aneurysms (mean,
17.6 mm; range, 11-47 mm). To achieve an adequate
landing zone, the helical branch was mated with stents
extending into a divisional trunk of the IIA in 35 cases
(34 posterior, one anterior). In the remaining 10, the distal
aspect of the IIA main trunk was adequate for seal. These
IIA aneurysm cases resulted in three of the nine technical
failures and all four cases of IBD-related endoleaks.
Despite an increase in the overall mating stent graft length
required (100.2 mm [range, 61-160] vs 76.7 mm [range,
36-121]) and a smaller distal vessel diameter (6.05 mm
[range, 4-9] vs 7.86 mm [range, 4-10]), the patency of
branches landing within a divisional branch was similar to
those sealing into the main IIA (Table III; 77.7% vs 83.1%
at 60 months; log-rank test, P ¼ .75).
IIA ostial stenosis. Five of nine technical failure
patients had severe IIA ostial stenosis. The stenosis
precluded IIA visualization following sheath placement in
Table II. Details of late occlusion (>30 days) of helical limbs, H-IBD, and BB-IBD
Details of failure/occlusion
Months
patent
Bilateral IIA occlusion
upon helical limb occlusion
Ischemia related
to occlusion
Proximal branch compression (4 mm) 1 Yes Nil
Proximal branch compression (2 mm) 2 No Hip claudication
Proximal branch compression (4 mm) 2 No Hip claudication
Proximal branch compression (4 mm) from extreme proximal IIA tortuosity 6 Yes Hip claudication
Occlusion secondary to left hypobranch EIA limb occlusion 6 No Nil
Extreme tortuosity in conjunction with a prolonged
episode of hypotension induced by an unrelated GI bleed
22 No Hip claudication
Retraction of distal graft into IIA An sac; no endoleak as thrombosed sac 26 Yes Hip claudication
BB-IBD, Bifurcated-bifurcated IBD; EIA, external iliac artery; GI, gastrointestinal; H-IBD, helical-IBD; IBD, iliac branch device; IIA, internal iliac artery.
All of the late occlusions with respect to timing and the development of ischemic symptoms are described here. Note the prevalence of the development of
unresolving hip/buttock claudication ipsilateral to the occlusion (71% of patients), detected by the patient at the time of the branch occlusion.
Table III. The effect of anatomic factors on device failure
IIA aneurysm Severe IIA ostial stenosis Narrow CIA bifurcation
Yes, %
(n ¼ 45)
No, %
(n ¼ 93) P
Yes, %
(n ¼ 27)
No, %
(n ¼ 111) P
Yes, %
(n ¼ 74)
No, %
(n ¼ 64) P
Technical successa 93.3 93.5 1 81.5 96.4 .015 95.3 91.9 .5
Endoleaka 6.7 1.1 .1 0.0 3.6 1 0.0 5.4 .12
Branch patencyb
30 days 97.6 93.1 88.7 96.1 91.8 97.1
12 months 87.4 85.8 81.0 87.7 83.6 88.9
24 months 87.4 83.1 81.0 84.8 83.6 84.9
48 months 77.7 83.1 81.0 81.5 83.6 80.2
60 months 77.7 83.1 .75 81.0 81.5 .45 83.6 80.2 .59
CIA, Common iliac artery; IIA, internal iliac artery.
aFisher exact test for technical failure and endoleak analysis.
bLog-rank test for branch patency.
The speciﬁc anatomic criteria that affects outcome following IBD placement is critical to patient selection and the development of new devices. This table
highlights the three primary factors: concomitant IIA aneurysms (requiring sealing zones deep in the pelvis), severe IIA ostial stenosis (potentially precluding
access and compressing mating stent grafts), and narrow distal CIA (preventing full expansion of the IBD) and how they inﬂuence technical success, endoleak,
and patency. Of note, only the presence of a severe IIA stenosis adversely affected technical success. Patency and endoleaks were unaffected by any variable. Of
note, we could not easily deﬁne tortuosity mathematically, so that was not measured.
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branch), an iatrogenic dissection in one patient, and in
the remaining two patients was unrelated to the source of
technical failure. Overall technical success was 81.5% in
patients with severe ostial stenosis vs 96.4% in patients
without (P ¼ .015), and patency at 30 days, 12, 24, 48,
and 60 months was 88.7%, 81.0%, 81.0%, 81.0%, and
81.0%, respectively (Table III; Fig 5). When compared
with patients without ostial stenosis, the patency was
similar (log-rank test, P ¼ .45).
Narrow distal CIA arteries (<16 mm). An approxi-
mate minimal CIA diameter of 18 mm is optimal for full
expansion of the device (8-mm branch and 12-mm EIA
limb). Initial experience was therefore limited to distal
diameters >18 mm, but over time, we became more
aggressive with smaller distal CIA diameters using a modi-
ﬁed implantation technique (described below). Sixty-four
of 138 branches (46%) were deployed in CIA bifurca-
tions with a diameter <16 mm (mean, 12.6 mm; range,
5-15 mm), and 74% of branches were placed in CIA withthrombus in the region of the IIA origin, yet these factors
did not inﬂuence technical success (Table III; 95.3% vs
91.9%; P ¼ .5) or patency. In such cases, after graft
deployment, a kissing-balloon technique involving a 6- to
8-mm balloon within the helical branch origin (via the
contralateral groin) and a 12-mm balloon within the EIA
limb of the IBD (via the ipsilateral groin) was often used.
The balloon within the helical branch was left inﬂated until
the nose cone of the IBD delivery system had been with-
drawn below the IIA ostium.
DISCUSSION
An IBD is likely the optimal means of endovascular
exclusion of CIA and IIA aneurysms, aiding us to extend
repairs from healthy arteries proximally to healthy arteries
distally. This approach does not compromise the sealing
zone within the CIA as snorkels, sandwiches, or bell-
bottom techniques may.8,12,13 The literature reports IBD
technical success rates >90%, primary patency rates of
between 74% and 100% and low endoleak rates at up to
Fig 5. Intraoperative pictures. a, Tight ostial lesion (A) and stent graft in situ (B). b, Internal iliac artery (IIA)
aneurysm (A), coiling of anterior divisional branch (B), and placement of mating stent into the posterior divisional
branch (C). c, Completed repair: infrarenal device (A) and fenestrated proximal device (B).
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selected patients. Our results support the use of these
devices, providing long-term follow-up with an evolved
design in patients with few anatomic restrictions, in addition
to analyzing morphologic details that may affect outcome.It must be understood that patient comorbidities and
anatomic factors may dissuade clinicians from treating all
CIA/IIA aneurysms with IBDs. Although we emphasized
strict physiologic exclusion principles (eg, overly sick
patients, those unable to exercise to claudication), very
Table IV. Assessment of H-IBD patients for exclusion
criteria for the PRESERVE-Zenith Iliac Branch System
Clinical Study
PRESEVE national trial exclusion criteria No. %
CIA <50 mm 33 24
EIA diameter <8 mm 9 7
IIA >10 mm 45 33
Aortic bifurcation angle <40 15 11
CIA minimum diameter <16 mm 62 45
None 28 20
1 65 47
2 38 28
3 6 4
4 1 1
CIA, Common iliac artery; EIA, external iliac artery; H-IBD, helical-IBD;
IBD, iliac branch device; IIA, internal iliac artery.
The Cook PRESERVE national trial utilizes the straight IBD device,
initially with a mating balloon-expandable stent graft and then moving to
a novel self-expanding stent graft made of Thoralon and Zilver stents.
However, strict anatomic criteria were applied to allow patients to be
enrolled in the trial. Our preoperative imaging data were reviewed for trial
acceptability, and only 20% of the patients treated with IBD devices met all
of the anatomic criteria for the trial. Estimates of anatomic acceptability
based on other author’s publications of less stringent anatomies are that 40%
of the patients in this study would be candidates for other reports.
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with signiﬁcant angulation, the need to seal deep within
the IIA circulation, bilateral disease, and severe occlusive
disease were all included in this series. The use of our
current devices broadens the anatomic applicability for
placement of these branched endografts. When the
anatomic enrollment criteria, as outlined in published
reports from iliac branched device feasibility studies, is
applied to patients we have treated with the H-IBD/BB-
IBD, only 20% of our treated patients would meet eligi-
bility for the IBD U.S. national trial (Table IV); this is
increased to 40% if enrollment criteria is based on enroll-
ment criteria endorsed by others.5,16 The combination of
H-IBD/BB-IBD permits treatment of virtually all patients
from an anatomic perspective, but we did not keep a log of
the reason for rejection of a patient from the IBD study
arms. This broadened applicability is critical in the setting
of extensive aneurysms where IIA compromise risks spinal
cord ischemia, as well as patients with bilateral disease
where claudication appears more profound. Coupled with
a limited number of device choices (a right- and left-sided
device), the desire to use an IBD should not complicate the
planning of endovascular procedures. These beneﬁts are
even more important when treating the Asian populations
where the average CIA length is considerably shorter than
in Caucasian patients (right CIA, 29.9 mm; left CIA, 34.2
mm),17 which is optimally suited for the BB-IBD.
In patients with unilateral disease, the decision to
occlude or preserve an IIA remains the subject of consider-
able debate. However, a signiﬁcant number of patients will
develop claudication if a single IIA is occluded,18 as did
71% of our late occlusion patients. It is our belief that
the claudication created by IIA loss is sustained andpatients “learn” not to walk. Unfortunately, we cannot
prove this point given that we only began routine treadmill
testing (pre- and postoperatively and during follow-up
studies) recently and, thus, have little long-term data.
Yet, it stands to reason that if one elects to treat superﬁcial
femoral artery disease for claudication, why would one elect
to cause claudication in aneurysm patients? Thus, clinicians
will have to balance the potential for claudication (or other
related complications) with the complexity, risk, and
implant costs of adding an IBD to an aortic repair.
The devices are also intended to simplify deployment
challenges in the setting of inherently tortuous anatomy.
Device orientation within a tortuous iliac system straight-
ened by stiff wires or delivery systems is difﬁcult to predict,
and accurate length measurements are hard to calculate
when faced with the inherently tortuous nature of the
IIA circulation due to ectasia, poststenotic dilations, and
IIA aneurysms. Yet, the long overlap zone of the 27-mm
helical branch allowed the use of only two mating devices
for virtually all patients after 2005 (10-mm-diameter
Fluency grafts, either 6 or 8 cm in length). The long over-
lap with the helical design allows one to focus almost
entirely on the accuracy of stent graft deployment at the
distal IIA landing zone, by providing ﬂexibility with
respect to the proximal overlap. Although the conﬁgura-
tion of the Viabahn (W. L. Gore) was initially appealing,
challenges were encountered with delivery and deploy-
ment accuracy in the setting of markedly tortuous situa-
tions, where the Fluency appeared to perform better
with these designs. Furthermore, the helical design allows
for smooth accommodation of the inherent angulation
between the IIA and CIA in aneurysmal disease, resulting
in little angulation within the completed branch (Fig 2).
Perhaps this explains the high patency rates and absence
of any fractures of the mating devices despite severe
angulation.
The ability to treat challenging situations improved as
we gained experience with the devices. In ostial IIA lesions,
initial technical failures resulted from an inability to visu-
alize the IIA after insertion of the device delivery system.
Here, we modiﬁed our implantation technique by snaring
the preloaded wire from the contralateral groin, with-
drawing the delivery system caudal to the IIA origin,
advancing an up-and-over sheath to allow cannulation
and placement of a 6-mm balloon into the IIA origin via
a second puncture in the sheath. The delivery system was
re-advanced into position with the IIA balloon inﬂated.
After IBD deployment, the balloon was removed leaving
a wire marking the IIA origin, and a third sheath puncture
allowed for introduction of a steerable catheter-guidewire
combination to cannulate the IIA from within the branch.
Similar improvements in our techniques were used in the
treatment of IIA aneurysms. We generally preserved the
posterior trunk of the IIA to avoid claudication. Here, after
initial IBD deployment, the anterior IIA trunk was
accessed through the sheath residing within the helical
branch and coiled. The mating stent graft was subsequently
placed into the posterior trunk obviating the need for
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stabilization for the embolization.
This series suffers from an absence of control patients
or randomized cohort, precluding ﬁrm comparisons
between IBD techniques and other methods of managing
iliac pathology. Furthermore, the duration of follow-up
varied, and we are unable to discuss results beyond 4 to
5 years with any signiﬁcant numbers. Finally, there is a clear
learning curve with IBD implantation, with greater experi-
ence improving our ability to treat more complex situa-
tions. The techniques learned were transferable to visceral
and supra-aortic trunk branch procedures. It seems
prudent to learn branch endografting techniques from
IBD procedures (where occlusion generally results in clau-
dication and endoleaks are easily treated by branch ostium
coverage) rather than in other beds where the repercus-
sions of failure are much greater. The actual proﬁciency
of any given clinician with the implantation of IBDs is difﬁ-
cult to pinpoint. The required skill set largely revolves
around endografting, but it also includes the ability to
snare wires, deep IIA embolization techniques, and chal-
lenging ostial IIA cannulations in the setting of tight
stenosis. Thus, most clinicians with experience in these
areas will quickly learn how to employ IBDs in their
practice, and others should take a more prudent
approach, beginning only with relatively straightforward
cases.
Overall, the two basic IBD conﬁgurations (H-IBDs
and BB-IBDs) allowed for the treatment of essentially all
patients with CIA/IIA aneurysms that had reasonable life
expectancies and exercise abilities. The ability to preserve
antegrade IIA ﬂow in patients with TAAAs may aid in
the prevention of spinal cord ischemia, whereas their appli-
cation in less extensive aneurysmal situations will help to
limit claudication and other more rare complications.
Anatomic exclusions were decidedly uncommon, and the
results in concomitant occlusive disease, IIA aneurysms,
and narrow CIA diameters were akin to more favorable
anatomies. The techniques and devices evolved over time
and currently are considered by experienced interventional-
ists as adding little complexity to the endovascular repair of
aortic aneurysms.
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